EMA: PRELIMINARY DATA FROM TRIALS SHOW ADAPTED MRNA VACCINES WHICH INCORPORATE OMICRON VARIANT STRAIN CAN RAISE & EXTEND PROTECTION, WHEN USED AS BOOSTER